This observation may reflect biological heterogeneity, as CD274 can mark an inflamed, T-cell-rich microenvironment associated with better prognosis, measurement variability, or residual confounding factors such as tumor burden or prior treatment, and thus should be interpreted cautiously. Here, CD274 is linked to neoplasm.